Headlines & Global News | FDA approves new blood pressure drug from Bayer Yahoo News The agency cleared the company's Adempas tablets for patients with two forms of pulmonary hypertension, which forces the heart to work harder to pump blood to the lung's arteries. When left untreated, the disease can lead to lung transplantation and death. FDA Gives Green Signal to Adempas to Treat Pulmonary Hypertension Adempas Approved to Treat Pulmonary Hypertension FDA Approves Drug For Pulmonary Hypertension Treatment |
